Brought to you by 
BG Medicine nets $37.4mm through its IPO
11 Feb 2011
Executive Summary
BG Medicine Inc. (cardiovascular, CNS, autoimmune, and metabolic diagnostics) has netted $37.4mm through the initial public offering of 5.75mm common shares (including the overallotment) at $7 each. Just weeks ago the company planned to sell 4.8mm shares between $13-15 each.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Bioinformatics
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
BG Medicine nets $37.4mm through its IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice